{"id":921498,"date":"2025-12-19T09:05:33","date_gmt":"2025-12-19T14:05:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/"},"modified":"2025-12-19T09:05:33","modified_gmt":"2025-12-19T14:05:33","slug":"mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/","title":{"rendered":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro"},"content":{"rendered":"<h2>\nStudy investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>MARIETTA, Ga., Dec.  19, 2025  (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion chorion membrane (LHACM) products, in the\u00a0<em>Journal of Inflammation<\/em>. The article, \u201cImmunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts <em>In Vitro<\/em>\u201d can be accessed online <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qzxAhPQT62d-xiRIK8mYpIcJ-KD5-h8FUGfWSd_7eyDK6fV5eIqITv5jLJB5Nltww_GZ3DtSsl2PvGk6tKa0lA==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\u201cOur team has once again demonstrated MIMEDX\u2019s commitment to generating robust and impactful peer-reviewed research, highlighting the capacity of our technology and the products that are derived from our proprietary tissue processing methodology,\u201d stated Joseph H. Capper, MIMEDX Chief Executive Officer. \u201cIn this latest publication, we were pleased to find that our DHACM and LHACM allografts exhibited immunomodulatory properties that correspond with the beneficial outcomes we observe in the clinical setting. This study marks another important contribution to our comprehensive library of clinical and scientific research, which has positioned us favorably in our marketplace, especially considering the renewed emphasis the pending Local Coverage Determinations (LCDs) place on the production of high-quality evidence.\u201d<\/p>\n<p>The study evaluated two configurations of Purion processed placental allografts, DHACM and LHACM, for their ability to regulate key cell types in the inflammatory cascade. The findings illustrate a multifactorial immunomodulatory effect whereby DHACM and LHACM allografts regulate critical functions of inflammatory monocyte and macrophage biology, while enhancing pro-reparative functions including efferocytosis and cell survival. This study is highly relevant, as complex wounds are frequently characterized by persistent inflammation within the wound bed, which contributes to chronicity and poor clinical outcomes; therefore, DHACM and LHACM represent promising interventions to help restore and reset the normal wound-healing cascade.<\/p>\n<p>\n        <strong>About MIMEDX<\/strong><br \/>\n        <br \/>MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company\u2019s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CUsjzxcYVwEK1ezbgMfal3r-XnOOmKRltGTFPPXBYxvLrvwbsQnypDlmHbrVwrstlMqYqZrC3We3OBNodmp5pg==\" rel=\"nofollow\" target=\"_blank\">www.mimedx.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Matt Notarianni<br \/>Investor Relations<br \/>470-304-7291<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zWQAJLI4YxRAXxOjzcx8DCjHovfczKX5IsBY2pya7sV_Utpdxi-9r0xl5E1zM7D-WF0JfIgip4Bnu-sZxB0FVbpJBg2E_qg7t67kwpg8Kao=\" rel=\"nofollow\" target=\"_blank\">mnotarianni@mimedx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDhjOGFhMTItNDRhMy00YTIxLWEzNTctYjViYjk0NzRlMDg1LTEwMjIxNTEtMjAyNS0xMi0xOS1lbg==\/tiny\/MiMedx-Group-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion chorion membrane (LHACM) products, in the\u00a0Journal of Inflammation. The article, \u201cImmunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts In Vitro\u201d can be accessed online here. \u201cOur team has once again demonstrated MIMEDX\u2019s commitment to generating robust and impactful peer-reviewed research, highlighting the capacity of our technology and the products that are derived &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-921498","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion chorion membrane (LHACM) products, in the\u00a0Journal of Inflammation. The article, \u201cImmunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts In Vitro\u201d can be accessed online here. \u201cOur team has once again demonstrated MIMEDX\u2019s commitment to generating robust and impactful peer-reviewed research, highlighting the capacity of our technology and the products that are derived &hellip; Continue reading &quot;MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-19T14:05:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro\",\"datePublished\":\"2025-12-19T14:05:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/\"},\"wordCount\":408,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/\",\"name\":\"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\",\"datePublished\":\"2025-12-19T14:05:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/","og_locale":"en_US","og_type":"article","og_title":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk","og_description":"Study investigates the influence of MIMEDX DHACM and LHACM products on inflammatory response, which supports the healing cascade and tissue repair MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) &#8212; MiMedx Group, Inc. (Nasdaq: MDXG) (\u201cMIMEDX\u201d or the \u201cCompany\u201d) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion chorion membrane (LHACM) products, in the\u00a0Journal of Inflammation. The article, \u201cImmunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts In Vitro\u201d can be accessed online here. \u201cOur team has once again demonstrated MIMEDX\u2019s commitment to generating robust and impactful peer-reviewed research, highlighting the capacity of our technology and the products that are derived &hellip; Continue reading \"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-19T14:05:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro","datePublished":"2025-12-19T14:05:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/"},"wordCount":408,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/","name":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=","datePublished":"2025-12-19T14:05:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwNTA5MCM3MzMwMTk4IzIwMTA1Nzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mimedx-announces-publication-in-the-journal-of-inflammation-focused-on-immunomodulatory-effects-of-purion-processed-human-amniotic-membrane-allografts-in-vitro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion\u00ae Processed Human Amniotic Membrane Allografts In Vitro"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/921498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=921498"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/921498\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=921498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=921498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=921498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}